Skip to content

Capture of Healthy Gut Bacteria Associated to High Fiber Diet

In Silico and in Vitro Targeting of Healthy Gut Bacteria With Fiber Degrading Metabolic Potential

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06166810
Acronym
iTARGET
Enrollment
10
Registered
2023-12-12
Start date
2023-10-24
Completion date
2026-12-31
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Population

Brief summary

The role of the intestinal microbiota on health is now well recognised, and diet is one of the factors influencing the maintenance of a healthy intestinal microbiota. More specifically, the consumption of fruit, vegetables and cereals is associated with good health and, in particular, with an increase in the relative abundance of bacterial groups described as beneficial. To date, a large number of bacterial species in the intestinal microbiota have yet to be isolated and cultivated, which limits the characterisation of their potential health benefits. In order to isolate and cultivate these intestinal bacteria, it is particularly relevant to recruit individuals with a high-fibre diet.

Detailed description

Since two decades, numerous studies have been performed to better understand the role of the gut microbiota in health and disease. An imbalance in the intestinal microbiota, known as dysbiosis, is frequently described as a cause of many chronic diseases and metabolic dysfunctions in humans. Among the factors that play an important role in maintaining this balance, diet plays a predominant role. More specifically, the consumption of fruit, vegetables and cereals is associated with good health and, in particular, with an increase in the relative abundance of bacterial groups described as beneficial. Modulating the intestinal microbiota via the or directly by providing these beneficial bacteria (next generation probiotics NGPs) is therefore a possible promising approach for the prevention and/or treatment of pathologies. To date, a large number of bacterial species in the intestinal microbiota have yet to be isolated and cultivated, which limits the characterization of their potential health benefits. Having strains that can be isolated and cultured is an essential step in phenotyping and characterization. In order to isolate and cultivate these intestinal bacteria, it is particularly important to recruit individuals with a high-fiber diet. In this context, a positive selection of donors, based on their dietary profiles highly enriched in fiber, is essential. In this study, the aim is to identify in silico unprecedented potentially new beneficial gut bacteria, and isolate, culture and characterize these bacterial species for their potential. This will be an innovative approach, using culturomics tools guided by metagenomics to isolate them. To do this, the fecal samples of 10 healthy volunteers will be collected with a regular and diversified intake of fruit, vegetables and cereals, which encourage the growth of beneficial micro-organisms and increase the richness of the intestinal microbiota.

Interventions

None listed

Sponsors

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Lead SponsorOTHER
Centre de Recherche en Nutrition Humaine d'Auvergne
CollaboratorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult subjects ; * Age between 20 and 50 (limits included) ; * BMI between 18.5 and 25 kg/m2 (excluding limits) ; * Consumption of more than 5 portions of fruit and vegetables a day; * Intake of at least 25g of dietary fibre per day; * A varied diet with little processed food.

Exclusion criteria

* Antibiotics and/or transit modulators taken in the 3 months prior to sampling; * Known pathologies; * Current treatment; * History of digestive surgery having an impact on the microbiota, deemed incompatible with the study (bariatric surgery); * Consumption of food supplements based on protein preparations, probiotics or prebiotics; * Smoking (even occasionally); * Alcohol consumption \> 2 glasses (i.e. 20 g) per day; * Intense sporting activity; * Pregnant or breast-feeding women; * Persons under legal protection (curatorship, guardianship, etc.); * Volunteers taking part in another intervention study; * Persons refusing to be registered on the French Ministry of Health's Fichier National des Volontaires Sains (National Register of Healthy Volunteers); * Subject not affiliated to the social security system; * Subject in a period of exclusion from a previous study or having received a total amount of compensation exceeding 6000 euros over the 12 consecutive months prior to the start of the trial (after verification in the Fichier des Volontaires pour la Recherche Biomédicale).

Design outcomes

Primary

MeasureTime frameDescription
Isolation and culture of one isolate from each target speciesUp to 3 yearsSuccessful isolation and culture of at least one isolate from each target species previously identified through metagenomic data analyses.

Secondary

MeasureTime frameDescription
metagenomic profiles in relation to dietary profilesUp to 3 yearsTo obtain metagenomic profiles using shotgun sequencing of the gut microbiota (bacterial species), in relation to dietary profiles
growth capacity of the isolatesUp to 3 yearsTo characterize the growth (growth monitoring by optical density) of the isolates of interest.
Functional potential of the isolatesup to 3 years.To characterize the genomic features of the isolates of interest (functional potential through genome annotation).
Phenotypic caracterization of the isolatesUp to 3 yearsTo characterize phenotypically the isolates of interest by API gallery.

Countries

France

Contacts

CONTACTAurélie CAILLE, MSc
acaille@chu-clermontferrand.fr04 73 75 42 73
CONTACTNathalie MEUNIER, PhD
nmeunier@chu-clermontferrand.fr04 73 75 42 73
STUDY_DIRECTORVictoria MESLIER, PhD

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

STUDY_DIRECTORClaire CHERBUY, PhD

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026